Corneal crosslinking check-up
Where are we and where are we going?
Private equity: What you need to know
It’s not coming to ophthalmology — it’s already here.
A roadmap for inlay success
Early adopters of corneal inlays say the route is easier than you might think.
The dry-eye prescribing headache
One practice administrator pleads for cooperation from all parties involved.
Partners in eye care, partners in business
A business partnership with an OD may make excellent sense for your practice and patients.
Learn to play cyber defense
It’s an ugly necessity: Cyber security will help maintain HIPAA website compliancy.
Dark adaptation as a clue to AMD
Clinical experience using a DA device to investigate the effect of drusen, disease subtypes and severities.
By Jordi Mon
A rare disorder appears in your clinic
Cogan syndrome’s symptoms are classically found in the eyes and ears.
Guest Editorial
EBK: a breakthrough in surface ablation
Viewpoint
FROM THE CHIEF MEDICAL EDITOR
As I See It
Thank you, Dr. Troutman
Coding & Reimbursement
Coding for the LT option
Quick Hits
By Laura Periman, MD
SPOTLIGHT ON TECHNOLOGY & TECHNIQUE
In pursuit of a perfect capsulorhexis
IN SO MANY WORDS
TearLab’s Seph Jensen
FINANCIAL FACTOR
Make use of section 179
THE ENLIGHTENED OFFICE
Translating literacy into education, and more
FROM THE EDITOR
How Low Can and Should You Go?
When is Glaucoma “Controlled”?
MIGS is changing the conventional wisdom in a way that’s beneficial for patients
Diagnosing & Managing Glaucoma: A Case Study
The importance of imaging the macula in glaucoma and its effects on patient education
Outliers & Moving Targets
Glaucoma management at the extremes of IOP
IOP At-home Monitoring
Assessing diurnal IOP fluctuations and modern day assessment with home rebound tonometry
Experts Discuss Tracking Glaucoma
Improving your view of the angle
Making History with ABiC
A story of two ophthalmologists — one doctor, one patient
A Simple Treatment Regimen at Last
Glaucoma specialists drive development of quality, sterile compounded medications to address compliance, cost, and tolerability
Innovative New Microstent for MIGS
The Hydrus Microstent bypasses the trabecular meshwork and dilates and augments the nasal quadrant of Schlemm’s canal
Addressing Drop Therapy’s Biggest Weakness
My experience with a new, simpler dosing option
Unbundle Modifiers
When used correctly, X modifiers support claims